Review on Stenotrophomonas maltophilia: An Emerging Multidrug- resistant Opportunistic Pathogen

Rikhia Majumdar1, Hariharan Karthikeyan1, Vaishnavi Senthilnathan1

  • 1Department of Genetic Engineering, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur-603203, Tamilnadu, India.

Insights

Stenotrophomonas maltophilia is a resilient opportunistic pathogen causing difficult-to-treat nosocomial infections. Its intrinsic resistance mechanisms and virulence factors pose significant challenges for effective antibiotic control.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Stenotrophomonas maltophilia is an opportunistic pathogen frequently causing nosocomial infections in immunocompromised patients.
  • It colonizes medical devices, leading to respiratory and urinary tract infections.
  • Multidrug resistance, efflux systems, and beta-lactamases complicate treatment.

Purpose of the Study:

  • To review current literature on Stenotrophomonas maltophilia.
  • To summarize pathogenicity, quorum sensing, biofilm formation, virulence factors, and antibiotic resistance.
  • To highlight challenges in combating this pathogen.

Main Methods:

  • Literature review of existing studies on Stenotrophomonas maltophilia.
  • Synthesis of data on virulence, resistance mechanisms, and treatment strategies.
  • Analysis of factors contributing to colonization and biofilm formation.

Main Results:

  • S. maltophilia exhibits intrinsic resistance to many antibiotics due to low outer membrane permeability and efflux systems.
  • Virulence factors facilitate colonization and biofilm formation on medical devices.
  • Acquisition of resistance genes via mutation and horizontal gene transfer exacerbates treatment difficulties.

Conclusions:

  • Controlling Stenotrophomonas maltophilia infections is challenging due to its adaptive resistance and virulence.
  • Understanding its pathogenicity and resistance mechanisms is crucial for developing new therapeutic strategies.
  • Further research is needed to overcome medicinal challenges posed by this pathogen.

Related Concept Videos

Rapid Identification of Pathogens01:25

Rapid Identification of Pathogens

MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...